COMMUNIQUÉS West-GlobeNewswire

Theratechnologies se classe au palmarès TSX30
26/09/2019
MONTRÉAL, 26 sept. 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) est heureuse d’annoncer qu’elle occupe la 21 e position du tout premier classement TSX30 des sociétés les plus [...]
Vaxart Announces Pricing of $8 Million Underwritten Public Offering
26/09/2019
SOUTH SAN FRANCISCO, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biopharmaceutical company focused on the development of oral recombinant vaccines based on its proprietary [...]
Pressure BioSciences’ PCT Platform Featured in Multiple Presentations at Major International Science Conference
26/09/2019
Ten Presentations by Scientists from Seventeen Research Institutions Worldwide Highlight Novel Applications for PBI’s PCT Platform in Cancer Research and Diagnostics South Easton, MA, Sept. 26, 2019 (GLOBE NEWSWIRE) -- [...]
Emergent BioSolutions to Participate in Cantor Fitzgerald Global Healthcare Conference
26/09/2019
GAITHERSBURG, Md., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s senior management team will participate in the Cantor Fitzgerald Global [...]
BAHAMAS: PROJECT HOPE PROVIDES URGENTLY NEEDED MEDICAL CARE TO HURRICANE DORIAN SURVIVORS
26/09/2019
Global health organization plans waves of medical teams through November Millwood, Virginia, Sept. 26, 2019 (GLOBE NEWSWIRE) -- The global health and humanitarian relief organization Project HOPE has deployed a medical [...]
CareDx Files Patent Infringement Lawsuit Against Eurofins Viracor
26/09/2019
CareDx protects transplantation innovation by enforcing patent protection BRISBANE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, [...]
NeuBase Therapeutics to Present at the Chardan 3rd Annual Genetic Medicines Conference
26/09/2019
PITTSBURGH, Sept. 26, 2019 (GLOBE NEWSWIRE) -- NeuBase Therapeutics, Inc. (NASDAQ: NBSE) (“NeuBase” or the “Company”), a biotechnology company developing next-generation antisense therapies to address genetic diseases, [...]
MannKind Corporation to Present at the 2019 Cantor Global Healthcare Conference
26/09/2019
WESTLAKE VILLAGE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ: MNKD) , a company focused on the development and commercialization of inhaled therapeutic products for patients with diseases [...]
The Silverstein Foundation and Q-State Biosciences Launch Chamishi Therapeutics
26/09/2019
NEW YORK and CAMBRIDGE, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- The Silverstein Foundation for Parkinson’s with GBA and Q-State Biosciences today announced the formation and launch of Chamishi Therapeutics, a drug [...]
Adamis Pharmaceuticals Announces Presentation Pertaining to Its High Dose Naloxone Product Candidate at IHV Scientific Meeting
26/09/2019
SAN DIEGO, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that Dr. Ronald Moss, Chief Medical Officer, will be presenting data on October 4, 2019, pertaining to the [...]
Zosano Pharma to Present at the Cantor Global Healthcare Conference
26/09/2019
FREMONT, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage biopharmaceutical company, today announced that its chairman, president and chief executive officer, John [...]
Helsinn demonstrates commitment to MF CTCL with multiple scientific sessions at the EORTC Cutaneous Lymphoma Meeting 2019
26/09/2019
Helsinn demonstrates commitment to MF CTCL with multiple scientific sessions at the EORTC Cutaneous Lymphoma Meeting 2019 Lugano, Switzerland, September 26, 2019 – Helsinn, the Swiss pharmaceutical group focused on [...]
Achillion to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
26/09/2019
BLUE BELL, Pa., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq: ACHN), a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients and families affected by [...]
Mustang Bio to Participate in October 2019 Investor Conferences
26/09/2019
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into [...]
Spero Therapeutics Announces Presentations at IDWeek 2019
26/09/2019
CAMBRIDGE, Mass., Sept. 26, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
Fortress Biotech to Present at October 2019 Investor Conferences
26/09/2019
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed and [...]
Checkpoint Therapeutics to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
26/09/2019
NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ: CKPT), a clinical-stage immuno-oncology biopharmaceutical company focused on the acquisition, development and [...]
XOMA to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
26/09/2019
EMERYVILLE, Calif., Sept. 26, 2019 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA) announced today its Chief Executive Officer, Jim Neal, will provide a corporate update at the 2019 Cantor Fitzgerald Global [...]
Ascendis Pharma A/S Announces Upcoming Investor Presentation in October
26/09/2019
COPENHAGEN, Denmark, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon™ technologies to address unmet medical needs, today announced [...]

Pages